These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3201416)

  • 1. [Drug therapy in arterial thromboembolic disease].
    Dale J
    Tidsskr Nor Laegeforen; 1988 Sep; 108(25):2038-9. PubMed ID: 3201416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protocols for the prevention and treatment of thromboembolic disease (III). Antithrombotic therapy in coronary disease. The Editorial Committee on Protocols (1)].
    Med Clin (Barc); 1994 Sep; 103(9):344-7. PubMed ID: 7967896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of the sequential treatment with defibrinating agents and plasminogenic urokinase in thromboembolic disease].
    Charbonnier B; Griguer P; Brochier M; Monpère C; Raynaud P
    Agressologie; 1983 Nov; 24(11):587-90. PubMed ID: 6670690
    [No Abstract]   [Full Text] [Related]  

  • 4. On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae.
    Ferliga G
    G Gerontol; 1966 Jun; 14(6):555-69. PubMed ID: 5989598
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of coronary arteriosclerosis and its complications].
    Giordano MP; Allegri M
    Clin Ter; 1972 Feb; 60(3):259-74. PubMed ID: 4665993
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboembolic disease and antithrombotic agents in the elderly. Preface.
    Jacobs LG
    Cardiol Clin; 2008 May; 26(2):xiii-xiv. PubMed ID: 18406990
    [No Abstract]   [Full Text] [Related]  

  • 7. New antithrombotic agents.
    Castelli R; Porro F; Savo D; Cassinerio E
    Panminerva Med; 2006 Dec; 48(4):247-56. PubMed ID: 17215797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of thrombophilia].
    Caruzzo C; Marcolongo M; Arpino E; Di Summa M
    Minerva Cardioangiol; 1981; 29(1-2):13-8. PubMed ID: 6112717
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolysis in cardiopulmonary disease.
    Chest; 1990 Apr; 97(4 Suppl):115S-181S. PubMed ID: 2323266
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy and prevention of thromboembolic diseases: anticoagulants and fibrinolytics].
    Pelosio L; Marasco A; Puopolo G
    Clin Ter; 1982 Feb; 100(4):417-25. PubMed ID: 7044661
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of venous thromboembolic (VTE) disease--Part II: Treatment.
    Kayser SR
    Prog Cardiovasc Nurs; 1996; 11(1):36-40, 46. PubMed ID: 8657708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Retinal artery occlusions. Apropos of several cases treated with thromboclase].
    Theron HP
    Arch Ophtalmol Rev Gen Ophtalmol; 1973; 33(8):615-8. PubMed ID: 4272353
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complications of fibrinolytic therapy].
    Hamet A; Pidrman V; Mazák J
    Vnitr Lek; 1979 Jul; 25(7):693-6. PubMed ID: 494505
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet-suppressive therapy in cardiovascular disease.
    Mehta J; Roy L
    Cardiovasc Clin; 1984; 14(3):211-34. PubMed ID: 6722852
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of venous thromboembolic disease].
    Laurent M; Rivalan J
    Soins Cardiol; 1985 Oct; (32):20-3. PubMed ID: 3853313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rivaroxaban: a decisive step forward in the management of postoperative thromboembolic disease?].
    Mantz J
    Ann Fr Anesth Reanim; 2008 Dec; 27 Suppl 3():S1. PubMed ID: 19185781
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of arterial thromboembolic disease.
    Meyer BJ; Chesebro JH
    Curr Opin Hematol; 1994 Sep; 1(5):336-40. PubMed ID: 9371302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic guidelines in diabetes.
    Sharma GV; Mukerjee DK; Sasahara AA
    Geriatrics; 1982 Apr; 37(4):38-42, 46. PubMed ID: 7060947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fibrinolytic system in arteriosclerosis.
    O'Brien ET
    J Ir Med Assoc; 1969 Jun; 62(384):203-12. PubMed ID: 4892241
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic agents and substances with "minor fibrinolytic" effect].
    Verstraete M; Amery A
    Rev Atheroscler (Paris); 1968; 10(2):21-7. PubMed ID: 5759946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.